CVC BRASIL (CVCB3) Main Indicators
Basic Data - CVCB3
| Company | CVC BRASIL |
| Corporate Name | CVC BRASIL OPERADORA E AGÊNCIA DE VIAGENS S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Serviços de turismo. compreendendo a intermediação. individualmente ou na forma agregada. de passagens aéreas. transporte terrestre. reservas de hotéis. passagens de cruzeiros marítimos. entre outros. |
| Share | CVCB3 |
| Quote Date | 11/19/2024 |
| Share Type | ON |
| Last Closing | R$ 2.37 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 52.92 M |
| Last Statement | ITR - 09/30/2024 |
| Sector | Consumo Cíclico |
| Subsector | Viagens e Lazer |
| Segment | Viagens e Turismo |
| Participation Indexes | IBOVESPA, IBRA, IBRX, ICON, IGC, IGCT, IGNM, ITAG, SMLL |
| Updated 11/21/2024 | |
Relative Prices - CVCB3
| Price/Earnings | -10.69 |
| Price/SBV | 2.14 |
| Price/Net Sales | 0.81 |
| Price/CFO | 6.71 |
| Price/FCF | 6.92 |
| Price/Total Assets | 0.32 |
| Price/EBIT | 17.89 |
| Price/Working Capital | -5.58 |
| Price/NCAV | -0.35 |
| EV/EBIT | 22.74 |
| EV/EBITDA | 5.37 |
| EV/Net Sales | 1.03 |
| EV/CFO | 8.53 |
| EV/FCF | 8.79 |
| EV/Total Assets | 0.40 |
| Company Market Cap | R$ 1.25 B |
| Enterprise Value | R$ 1.58 B |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 2.37 |
| Share Price Date | 11/19/2024 |
| Dividend Yield | 0.00% |
| Updated 11/21/2024 | |
Income Statement - CVCB3
| Net Revenue | R$ 1.54 B |
| Gross Result | R$ 1.31 B |
| EBIT | R$ 69.62 M |
| Depreciation and Amortization | - R$ 225.36 M |
| EBITDA | R$ 294.98 M |
| Net Profit | - R$ 116.58 M |
| Net Profit/Share | - R$ 0.22 |
| Updated 11/12/2024 | |
| Net Revenue | R$ 375.81 M |
| Gross Result | R$ 347.02 M |
| EBIT | R$ 43.75 M |
| Depreciation and Amortization | - R$ 55.24 M |
| EBITDA | R$ 98.99 M |
| Net Profit | R$ 14.44 M |
| Profit/Share | R$ 0.03 |
| Updated 11/12/2024 | |
Price and Volume Behavior - CVCB3
| Lowest Price 52 weeks | R$ 1.71 |
| Highest Price 52 weeks | R$ 4.01 |
| Variation 2024 | -27.74% |
| Variation 1 year | -22.30% |
| Variation 2 years(total) | -57.98% |
| Variation 2 years(yearly) | -35.10% |
| Variation 3 years(total) | -84.49% |
| Variation 3 years(yearly) | -46.24% |
| Variation 4 years(total) | -85.22% |
| Variation 4 years(yearly) | -38.00% |
| Variation 5 years(total) | -93.86% |
| Variation 5 years(yearly) | -42.74% |
| Average Daily Volume (3 months) | R$ 37.78 M |
| Updated 11/21/2024 | |
Returns and Margins - CVCB3
| Return on Initial Tangible Capital | 17.37% |
| Return on Initial Invested Capital | 4.73% |
| Pre-Tax Return on Initial Tangible Capital | 26.32% |
| Pre-Tax Return on Initial Invested Capital | 7.17% |
| Return on Initial Shareholder´s Equity | -26.71% |
| Return on Initial Asset | -2.90% |
| Gross Margin | 85.24% |
| Net Margin | -7.58% |
| EBIT Margin | 4.53% |
| EBITDA Margin | 19.18% |
| Initial Asset Turnover | 0.38 |
| Financial Leverage | 6.77 |
| Liabilities/Net Worth | 5.77 |
| Net Debt/EBITDA | 1.14 |
| Updated 11/12/2024 | |
Balance Sheet - CVCB3
| Cash and Cash Equivalents | R$ 383.45 M |
| Total Assets | R$ 3.94 B |
| Short-Term Debt | R$ 100.38 M |
| Long-Term Debt | R$ 620.48 M |
| Gross Debt | R$ 720.86 M |
| Net Debt | R$ 337.41 M |
| Shareholder´s Equity | R$ 582.17 M |
| Share Book Value | R$ 1.11 |
| Common Shares | 525,591,097 |
| Preferred Shares | 0 |
| Total | 525,591,097 |
| Common Shares in Treasury | 8,326 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 8,326 |
| Common Shares (Except Treasury) | 525,582,771 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 525,582,771 |
| Updated 11/12/2024 | |
Cash Flow - CVCB3
| Operating Cash Flow | R$ 185.60 M |
| Cash Flow from Investments | - R$ 78.82 M |
| Financing Cash Flow | R$ 48.03 M |
| Increase (Reduction) in Cash and Equivalents | R$ 161.86 M |
| Updated 11/12/2024 | |
| Operating Cash Flow | R$ 169.22 M |
| Cash Flow from Investments | - R$ 23.56 M |
| Financing Cash Flow | - R$ 4.78 M |
| Increase (Reduction) in Cash and Equivalents | R$ 139.29 M |
| Updated 11/12/2024 | |
Experimental - CVCB3
| CAPEX 3 months | - R$ 622.00 thousand |
| Free Cash Flow 3 months | R$ 168.60 M |
| CAPEX 12 months | - R$ 5.59 M |
| Free Cash Flow 12 months | R$ 180.01 M |
| Updated 11/12/2024 | |